Paasa Logo
Zoetis Inc. logo
ZOEXETRAMarket openCloses 5:30pm CET

Zoetis Inc.

€61.86Last updated
-€0.46 (0.74%)Past day
Timezone

Zoetis Inc. (XETRA: ZOE) is trading at €61.86, about ₹6,733 at today's EUR/INR rate, as of 30 Sep 2026, 11:35 AM ET, down 0.74% today. Indian residents can buy Zoetis from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:€62.34
Previous close:€62.32
Volume:602.00

Today's low

€61.86

Today's high

€62.48

52 week low

€61.16

52 week high

€128.16

ZOE opened at €62.34, closed previously at €62.32, and has traded between €61.16 and €128.16 over the past 52 weeks.

About

Zoetis Inc. is a global enterprise dedicated to the research, development, production, and marketing of a broad spectrum of animal health products. Operating both within the United States and globally, the company primarily serves a diverse range of animals, including major livestock categories such as cattle, swine, poultry, fish, and sheep, alongside companion animals like dogs, cats, and horses. Their extensive portfolio features various solutions, including biological vaccines engineered to prevent ailments of the respiratory, gastrointestinal, and reproductive systems, or to stimulate targeted immune responses. They also provide anti-infectives designed to combat bacterial, fungal, or protozoal pathogens, and parasiticides effective against both internal (e.g., worms) and external (e.g., fleas, ticks) parasites. Beyond these, Zoetis offers a suite of other pharmaceutical products, spanning pain management, sedation, antiemetics, reproductive aids, and oncology treatments. Their offerings also include dermatological solutions for allergic skin conditions and atopic dermatitis, as well as medicated feed additives specifically for livestock. The company further innovates in diagnostic tools, offering portable blood and urine analysis systems, point-of-care devices, instruments, reagents, rapid immunoassay tests, reference laboratory services, and blood glucose monitors. Non-pharmaceutical lines extend to nutritional supplements, agribusiness support, biodevices, genetic testing, and precision animal health technologies. Zoetis reaches its customer base, which comprises veterinarians, livestock producers, and retail outlets, through its own sales representatives and specialized technical and veterinary operations personnel, as well as via third-party veterinary distributors. Founded in 1952, the firm maintains its headquarters in Parsippany, New Jersey.

Country
US
CEO
Kristin C. Peck
Exchange listed on
XETRA
Industry
Drug Manufacturers - Specialty & Generic
Base currency
EUR
Full Time Employees
14,500
Sector
Healthcare
IPO date
11/11/2019

Key statistics

Avg. volume

2.10K

Market cap

€25.93B

P/E Ratio

11.49

Price-to-sales ratio

3.08

Enterprise value

$62.82B

Free cash flow yield

4.08%

Debt-to-equity ratio

2.93

Return on equity

80.25%

ROIC

21.63%

Beta

0.73

Dividend yield

2.99%

Last dividend

€1.79

Financial overview

Revenue

$9.47B

Earnings per share

$6.03

Free cash flow

$2.28B

Net profit margin

27.49%

Gross margin

70.87%

EBITDA

$4.07B

Revenue growth

2.28%

Similar securities

This is not an investment recommendation

How to buy Zoetis from India

Indian residents can buy Zoetis shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.

  3. Search for Zoetis and place an order

    Find Zoetis by name or by its ticker, ZOE, and choose an order type. Zoetis trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Zoetis position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Zoetis from India

Trading and taxes when buying Zoetis from India

Trading and limits

Trading hours
9:00 am – 5:30 pm CET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Zoetis’ current yield is 2.99%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Zoetis stock?

Yes. Zoetis (ZOE) has been listed on XETRA since 2019, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Zoetis share cost in rupees?

One Zoetis share is €61.86 — about ₹6,733 at an EUR/INR rate of 108.84 on 30 Sep 2026. Both the Zoetis price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Zoetis from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

How are gains on Zoetis shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the Zoetis price. Paasa issues a capital-gains statement for your return.

Does Zoetis pay a dividend, and how is it taxed in India?

Yes. Zoetis pays a dividend and the current yield is 2.99%; the last declared dividend was €1.79 per share, about ₹195.14. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Zoetis from India?

XETRA trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when Germany is on standard time. Orders can only execute during that window.

Is Zoetis a Germany company, and does that change how it is taxed?

Zoetis trades on XETRA in EUR, but the company is domiciled in United States. Zoetis trades as an ordinary share listed directly in Germany, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Zoetis shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Zoetis holding, its cost and its closing value.

How do I sell Zoetis and bring the money back to India?

You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.

Does the rupee rate affect what I make on Zoetis?

Yes. Zoetis is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.